Takeda Pharmaceuticals Ltd.,   

Antitumor agent - antibodies monoclonal

Lyophilizate for the preparation of concentrate for the preparation of a solution for infusions, 50 mg.

regeneration of tissue stimulant

Solution for injection, 40 mg / ml.

Regeneration of tissue stimulant
The coated tablets are 200 mg.
Beta1-blocker selective

Film coated tablets 50 mg and 100 mg.

Diuretics
Long-acting tablets 5 mg and 10 mg.
Expectorant mucolytic agent

Solution for oral administration 0.8 mg / ml.

An antianemic agent, an iron preparation for parenteral administration

Solution for intravenous administration, 20 mg / ml.

Vitamin - calcium-phosphorus exchange regulator

Solution for oral ingestion, 0.5 mg / ml.

Hypoglycemic agent - dipeptidyl peptidase-4 inhibitor (DPP-4)
Tablets coated with a film coating of 12.5 mg and 25 mg.
The iron of the stomach secretion is a reducing agent - a proton pump inhibitor

Capsules with a modified release of 30 mg and 60 mg.

antibiotic-carbapenem

Powder for solution for infusion, 500 mg.

Calcium-phosphorus exchange regulator
Tablets are chewing (orange), 500 mg + 200 ME.
Calcium-phosphorus exchange regulator
Tablets chewing (lemon), 500 mg + 400 ME.
Antiaggregant agent

Film coated tablets 75 mg +15.2 mg and 150 mg + 30.39 mg.

antiallergic agent - H1-histamine receptor blocker
Tablets lyophilized, 20 mg.
antiallergic agent - H1-histamine receptor blocker

Tablets, film-coated, 20 mg.

antiallergic agent - H1-histamine receptor blocker

Tablets, film-coated, 10 mg.

antihypertensive drug combined (beta-blocker + BCCC)

Tablets, 5 mg + 5 mg, 5 mg + 10 mg, 10 mg + 5 mg and 10 mg + 10 mg.

glands of the stomach secretion-lowering agent - proton pump inhibitor

Powder for the preparation of a solution for intravenous administration of 40 mg.

glands of the stomach secretion-lowering agent - proton pump inhibitor

Tablets coated with enteric coating 40 mg.

Non-steroidal anti-inflammatory drug (NSAID)

Liofilizate for the preparation of solution for intravenous and intramuscular injection.

Non-steroidal anti-inflammatory drug (NSAID)

Film coated tablets 4 mg and 8 mg.

Non-steroidal anti-inflammatory drug (NSAID)
The coated tablets are 8 mg.
anticonvulsant agent-vasoconstrictor (alpha-adrenomimetic)

Spray nasal dosed with 140 mcg / dose.

For 10 ml of the preparation (not less than 60 doses) in a plastic bottle equipped with pump metering device with a tip and a protective cap of polyethylene. By 1 A bottle together with the instructions for application is placed in cardboard pack.

antipsychotic agent (antipsychotic)

Film coated tablets, 20 mg, 40 mg and 80 mg.

Muscle relaxant depolarizing the peripheral action
A solution for intravenous and intramuscular administration of 20 mg / ml.
antihypertensive drug combined (beta 1-blocker selective + diuretic)

Film-coated tablets, 2.5 mg + 6.25 mg, 5 mg + 6.25 mg and 10 mg + 6.25 mg.

The iron preparation

Drops for ingestion 50 mg / ml.

The iron preparation

Solution for intramuscular injection 50 mg / ml.

The iron preparation
Tablets chewing 100 mg.
The iron preparation

Syrup 10 mg / ml.

The iron preparation
Solution for oral administration 20 mg / ml.
Iron preparation + vitamin

Tablets chewing 100 mg + 0.35 mg.

antimicrobial and antiprotozoal agent

Tablets, film-coated, 500 mg.

cradle

Powder for solution for oral administration.

Antitussive medication - alpha-adrenomimetic

The nasal spray is 11.25 μg / dose and 22.5 μg / dose.

Antitumor agent

Capsules 2.3 mg, 3 mg and 4 mg.

glucocorticosteroid
Tablets, 5 mg.
glucocorticosteroid

Solution for intravenous and intramuscular administration, 25 mg / ml.

Hemostatic agent for topical application.
Sponge.
analgesic narcotic
The transdermal therapeutic system is 12.5 μg / hr, 25 μg / hr, 50 μg / hr, 75 μg / hr, 100 μg / hr.
The iron preparation.

Solution for intravenous administration 50 mg / ml.

By 2 ml or 10 ml of the drug in bottles of clear, colorless glass type I (Ph.Eur.), Sealed with brombutyl rubber stoppers and crimped with aluminum caps with plastic inserts such as "Flip off".

1 bottle of 2 ml or 10 ml with instructions for use in a cardboard pack.

2 bottles of 10 ml in a plastic pallet holder together with instructions for use in a cardboard bundle.

5 vials of 2 ml or 10 ml in a plastic holder holder together with instructions for use in a cardboard bundle.

Nootropic remedy

Solution for intravenous and intramuscular injection, 500 mg / 4 ml and 1000 mg / 4 ml.

nootropic remedy

Solution for oral administration, 100 mg / ml.

Alpha-blocker

Capsules of prolonged action, 30 mg and 60 mg.

Alpha-blocker

Solution for intravenous administration, 5 mg / ml.

Angiotensin II receptor antagonist

Tablets of 20 mg, 40 mg and 80 mg.

A combined hypotensive drug (angiotensin II receptor antagonist + diuretic)

Film coated tablets 40 mg + 12.5 mg, 40 mg + 25 mg.

Immunosuppressive means - antibodies monoclonal

Lyophilizate for the preparation of concentrate for the preparation of a solution for infusions, 300 mg.

Nootropic agent.

Suspension for oral administration.

Nootropic agent.

Tablets coated with 100 mg.